UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

Journal of clinical oncology, 2008-06, Vol.26 (18), p.3063-3072

2008

Volltextzugriff (PDF)

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1083-1090

2011

Volltextzugriff (PDF)

Improving resectability of hepatic colorectal metastases: expert consensus statement

Annals of surgical oncology, 2006-10, Vol.13 (10), p.1271-1280

2006

Volltextzugriff (PDF)

Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

Journal of clinical oncology, 2006-05, Vol.24 (13), p.2065-2072

2006

Volltextzugriff (PDF)

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5344-5351

2008

Volltextzugriff (PDF)

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Annals of surgical oncology, 2009-04, Vol.16 (4), p.836-847, Article 836

2009

Volltextzugriff (PDF)

Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis

Annals of surgical oncology, 2007-12, Vol.14 (12), p.3481-3491

2007

Volltextzugriff (PDF)

Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma

Journal of clinical oncology, 2011-10, Vol.29 (29), p.3892-3899

2011

Volltextzugriff (PDF)

Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5254-5260

2008

Volltextzugriff (PDF)

Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome

Journal of surgical oncology, 2010-12, Vol.102 (8), p.960-967

Abdalla, Eddie K.

2010

Volltextzugriff (PDF)

Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy

Annals of surgical oncology, 2009-03, Vol.16 (3), p.614-622

2009

Volltextzugriff (PDF)

Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease

Annals of surgical oncology, 2006-05, Vol.13 (5), p.712-720

2006

Volltextzugriff (PDF)

Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis

Annals of surgical oncology, 2007-10, Vol.14 (10), p.2807-2816

2007

Volltextzugriff (PDF)

Curable metastatic colorectal cancer: Recommended paradigms

Current oncology reports, 2009-05, Vol.11 (3), p.200-208

2009

Volltextzugriff (PDF)

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

Cancer, 2010-04, Vol.116 (8), p.1938-1946

2010

Volltextzugriff (PDF)

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study

Journal of surgical oncology, 2004-01, Vol.85 (1), p.36-41

2004

Volltextzugriff (PDF)

Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

Annals of surgical oncology, 2010-11, Vol.17 (11), p.2870-2876

2010

Volltextzugriff (PDF)

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

Cancer, 2007-12, Vol.110 (12), p.2761-2767

2007

Volltextzugriff (PDF)

A Proposed Staging System for Intrahepatic Cholangiocarcinoma

Annals of surgical oncology, 2009, Vol.16 (1), p.14-22

2009

Volltextzugriff (PDF)

The Development and Characterization of a Human Midgut Carcinoid Cell Line

Clinical cancer research, 2007-08, Vol.13 (16), p.4704-4712

2007

Volltextzugriff (PDF)

Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases

Annals of surgical oncology, 2008-10, Vol.15 (10), p.2765-2772

2008

Volltextzugriff (PDF)

Portal Vein Embolization in Hilar Cholangiocarcinoma

Surgical oncology clinics of North America, 2009-04, Vol.18 (2), p.257-267

2009

Volltextzugriff (PDF)

Hepatic Resection for Gastrointestinal Stromal Tumor Liver Metastases

Hematology/oncology clinics of North America, 2009-02, Vol.23 (1), p.115-127

2009

Volltextzugriff (PDF)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

Annals of surgical oncology, 2010-07, Vol.17 (7), p.1794-1801

2010

Volltextzugriff (PDF)

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

Annals of surgical oncology, 2012-06, Vol.19 (6), p.2045-2053

2012

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)
Buchkapitel
(1)

Sprache

Englisch
(52)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

Improving resectability of hepatic colorectal metastases: expert consensus statement

Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis

Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma

Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases

Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome

Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy

Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease

Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis

Curable metastatic colorectal cancer: Recommended paradigms

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study

Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

A Proposed Staging System for Intrahepatic Cholangiocarcinoma

The Development and Characterization of a Human Midgut Carcinoid Cell Line

Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases

Portal Vein Embolization in Hilar Cholangiocarcinoma

Hepatic Resection for Gastrointestinal Stromal Tumor Liver Metastases

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

Aktive Filter

Suchergebnisse filtern